SY 5555

Known as: SY-5555, SY5555 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1992-1994
012319921994

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1995
1995
Furopenem is a novel orally active penem. In this study, furopenem was highly active in vitro against Streptococcus pneumoniae… (More)
Is this relevant?
1995
1995
SY5555 is a new oral penem antibiotic. Pharmacokinetic and clinical studies using SY5555 dry syrup (powder which is dissolved… (More)
Is this relevant?
1995
1995
We assessed the in vitro antimicrobial activity and the clinical efficacy and safety of SY5555 in the field of pediatrics. The… (More)
Is this relevant?
1995
1995
Laboratory and clinical studies were performed on SY5555, the first penem oral antibiotic developed in Japan, in the pediatric… (More)
Is this relevant?
1995
1995
A clinical study was performed on SY5555, a newly developed penem antibiotic, in children. SY5555 was given orally to 14 patients… (More)
Is this relevant?
1995
1995
Pharmacokinetic, bacteriological and clinical studies on SY5555, a new oral penem, were carried out, and the following results… (More)
Is this relevant?
1994
1994
The antibacterial activity of SY5555, a new oral penem antibiotic, was compared with those of cefaclor, cefixime, and cefteram… (More)
Is this relevant?
1994
1994
A multicenter clinical study was carried out to investigate the clinical efficacy of SY5555 from viewpoint of its MIC breakpoint… (More)
Is this relevant?
1994
1994
SY5555, a new oral penem, was pharmacokinetically and clinically evaluated in the pediatric field and the following results were… (More)
Is this relevant?
1992
1992
To prove the free-ligand hypothesis for extravascular equilibration and tissue binding mechanism of beta-lactam antibiotics, the… (More)
Is this relevant?